Full Automaticity and Remote Follow-up
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01526629|
Recruitment Status : Completed
First Posted : February 6, 2012
Results First Posted : June 29, 2017
Last Update Posted : June 29, 2017
With the expansion of Sudden Cardiac Death (SCD) primary prevention indications, the number of Implantable Cardioverter Defibrillators (ICD) implants has increased significantly in the recent years. This has resulted in an increase of the number of follow-up (FU) to be performed and a growing workload for centers. Remote FU system such as the Medtronic Carelink system allows to check remotely the proper functioning of self evaluating devices and give informations of some clinical events.
The objective of this study is to define which patients with a remote follow-up need additional onsite visit and to assess to which extent remote FU can be an alternative to onsite visit.
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||354 participants|
|Official Title:||Identification of Implantable Cardioverter Defibrillator Patients With Remote Follow up That Requires an Onsite Visit|
|Study Start Date :||May 2011|
|Actual Primary Completion Date :||March 2015|
|Actual Study Completion Date :||March 2015|
ICD patients with remote follow-up
Patients implanted with a fully automatic ICD and remotely followed-up.
- Remote Follow-up as an Alternative to Onsite Visit [ Time Frame: 13 months ]Evaluate the percentage of patients who had a successful remote follow up, as an alternative to onsite visit for patients implanted with a fully automatic ICD
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01526629
|Montfermeil, France, 93370|
|Principal Investigator:||Walid Amara, MD||Centre Hospitalier de Montfermeil|